Breschi, G. L., Demma, F., Morelli, P., & De Francesco, M. (2021). Brentuximab vedotin in adult patients with HL CD30+ at high risk of relapse or progression following ASCT: a cost-analysis in Italy. AboutOpen, 8(1), 81–87. https://doi.org/10.33393/ao.2021.2263